Schedule of segment reporting information, by segment |
|
|
Year ended
|
|
|
December 31, 2021
|
|
December 31, 2020
|
Segment Net Sales:
|
|
|
|
|
|
|
|
|
Cannabinoid
|
|
$
|
3,242 |
|
|
$
|
2,511 |
|
Non-Cannabinoid
|
|
|
12,132 |
|
|
|
9,606 |
|
Total Net Sales
|
|
|
15,374 |
|
|
|
12,117 |
|
|
|
|
|
|
|
|
|
|
Segment Profit (Loss):
|
|
|
|
|
|
|
|
|
Cannabinoid
|
|
|
(16,915 |
)
|
|
|
(18,798 |
)
|
Non-Cannabinoid
|
|
|
2,631 |
|
|
|
1,863 |
|
Total Loss
|
|
$
|
(14,284 |
)
|
|
$
|
(16,935 |
)
|
|
|
|
|
|
|
|
|
|
Reconciliation:
|
|
|
|
|
|
|
|
|
Total Segment Loss
|
|
|
(14,284 |
)
|
|
|
(16,935 |
)
|
Unallocated corporate expenses
|
|
|
(11,196 |
)
|
|
|
(6,405 |
)
|
Non-cash share based compensation
|
|
|
(11,451 |
)
|
|
|
(1,652 |
)
|
Depreciation and amortization
|
|
|
(1,768 |
)
|
|
|
(1,854 |
)
|
Goodwill impairment
|
|
|
(18,508 |
)
|
|
|
(1,682 |
)
|
Loss from operations
|
|
$
|
(57,207 |
)
|
|
$
|
(28,528 |
)
|
|
|
|
|
|
|
|
|
|
(Gain) loss on debt extinguishment, net
|
|
|
(3,262 |
)
|
|
|
2,360 |
|
Gain on remeasurement of warrant liability
|
|
|
(16,856 |
)
|
|
|
(10,780 |
)
|
Loss on fair value of derivative instrument
|
|
|
|
|
|
|
657 |
|
Loss on investments
|
|
|
|
|
|
|
464 |
|
Foreign exchange loss
|
|
|
1,276 |
|
|
|
491 |
|
Interest expense
|
|
|
6,818 |
|
|
|
4,455 |
|
Other income, net
|
|
|
(502 |
)
|
|
|
(284 |
)
|
Loss from operations before income taxes and equity investment loss
|
|
$
|
(44,681 |
)
|
|
$
|
(25,891 |
)
|
|
|
December31, 2021
|
|
December31, 2020
|
Long-lived assets
|
|
|
|
|
|
|
Cannabinoid
|
|
$
|
30,709 |
|
$
|
25,485 |
Non-Cannabinoid
|
|
|
216 |
|
|
176 |
Other(a)
|
|
|
7 |
|
|
19 |
|
|
$
|
30,932 |
|
$
|
25,680 |
|
Disaggregation of revenue by channel |
|
|
Year ended
|
|
|
December 31, 2021
|
|
December 31, 2020
|
Mass retail
|
|
$
|
8,070 |
|
$
|
6,879 |
Distributors
|
|
|
5,835 |
|
|
4,036 |
Specialty, health and other retail
|
|
|
945 |
|
|
689 |
E-commerce
|
|
|
524 |
|
|
513 |
|
|
$
|
15,374 |
|
$
|
12,117 |
|